• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Kezar Life Sciences released FY2025 9 Months earnings on November 12, 2025 (EST), actual revenue USD 0, actual EPS USD -5.6737
04:00
Kezar Life Sciences released FY2025 Q3 earnings on November 12, 2025 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -1.533 (forecast USD -1.9475)
04:00
Nov7
Kezar Life Sciences Announces Positive Results from Phase 2 Clinical Trials of Zetomipzomib
12:03
Oct17
Phipps covers healthcare sector and focuses on related stocks
08:31
Aug14
Kezar Life Sciences released FY2025 Semi-Annual earnings on August 13 (EST) with actual revenue of USD 0 and EPS of USD -4.1404
03:00
Kezar Life Sciences released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.8744 (forecast USD -2.2866)
03:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -11.23 M, EPS -1.533

Aug13
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -13.7 M, EPS -1.8744

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -16.56 M, EPS -2.2661

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SOBR
2.370
+82.31%
+1.070
OMER
15.360
+75.54%
+6.610
NCL
0.2560
+49.45%
+0.085
AMCI
9.350
+47.94%
+3.030
EUDA
2.770
+44.27%
+0.850
DVAX
15.380
+38.19%
+4.250
MWG
0.3496
+38.13%
+0.097
INDP
2.650
+35.90%
+0.700
SIDU
2.200
+33.33%
+0.550
FMFC
0.3929
+28.74%
+0.088
View More